The same study reported both CCL4 and CCR5 levels to significantly reduce in response to a low‐dose statin treatment, of which the former's reduction has been reported by others as well [54], albeit in a cohort of patients with coronary artery disease. The gene discussed is CCL4; the disease is coronary artery disorder.